Tecan Group AG (SWX: TECN)

Market Cap	3.03B
Revenue (ttm)	1.00B
Net Income (ttm)	101.34M
Shares Out	12.83M
EPS (ttm)	7.89
PE Ratio	29.92
Forward PE	28.09
Dividend	3.00 (1.27%)
Ex-Dividend Date	Apr 22, 2024

Volume	34,287
Average Volume	50,385
Open	239.20
Previous Close	238.60
Day's Range	235.60 - 239.20
52-Week Range	192.70 - 392.00
Beta	0.75
RSI	66.12
Earnings Date	Mar 12, 2025

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The compa...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 3,573
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: TECN

Financial Performance

In 2023, Tecan Group AG's revenue was 1.07 billion, a decrease of -6.11% compared to the previous year's 1.14 billion. Earnings were 132.08 million, an increase of 9.04%.